CIBC World Market
ONCY

CIBC World Market’s Oncolytics Biotech ONCY Stock Holding History

CIBC World Market’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$51.3K Sell
60,303
-10,105
-14% -$10K ﹤0.01% 1445
2025
Q4 		$61.3K Buy
70,408
+10,027
+17% +$10.8K ﹤0.01% 1421
2025
Q3 		$84.5K Hold
60,381
– – ﹤0.01% 1379
2025
Q2 		$46.1K Buy
60,381
+1,105
+2% +$585 ﹤0.01% 1331
2025
Q1 		$32.5K Buy
59,276
+596
+1% +$436 ﹤0.01% 1338
2024
Q4 		$54K Buy
58,680
+845
+1% +$879 ﹤0.01% 1333
2024
Q3 		$51K Hold
57,835
– – ﹤0.01% 1275
2024
Q2 		$57K Sell
57,835
-315
-0.5% -$343 ﹤0.01% 1234
2024
Q1 		$62K Sell
58,150
-2,737
-4% -$3.06K ﹤0.01% 1263
2023
Q4 		$82K Sell
60,887
-26
-0% -$41 ﹤0.01% 1209
2023
Q3 		$133K Hold
60,913
– – ﹤0.01% 1175
2023
Q2 		$161K Sell
60,913
-168
-0.3% -$279 ﹤0.01% 1153
2023
Q1 		$75K Buy
61,081
+22
+0% +$35 ﹤0.01% 1195
2022
Q4 		$100K Sell
61,059
-420
-0.7% -$638 ﹤0.01% 1201
2022
Q3 		$77K Buy
61,479
+12
+0% +$15 ﹤0.01% 1185
2022
Q2 		$60K Sell
61,467
-7,486
-11% -$9.1K ﹤0.01% 1219
2022
Q1 		$109K Buy
68,953
+8,324
+14% +$14K ﹤0.01% 1248
2021
Q4 		$84K Sell
60,629
-1,025
-2% -$1.9K ﹤0.01% 1289
2021
Q3 		$129K Sell
61,654
-286
-0.5% -$648 ﹤0.01% 1289
2021
Q2 		$172K Sell
61,940
-52
-0.1% -$159 ﹤0.01% 1283
2021
Q1 		$236K Hold
61,992
– – ﹤0.01% 1158
2020
Q4 		$148K Buy
61,992
+1,304
+2% +$3.12K ﹤0.01% 1218
2020
Q3 		$103K Sell
60,688
-395
-0.6% -$725 ﹤0.01% 1064
2020
Q2 		$115K Buy
61,083
+43,683
+251% +$82.2K ﹤0.01% 1033
2020
Q1 		$24K Buy
17,400
+207
+1% +$517 ﹤0.01% 966
2019
Q4 		$82K Buy
+17,193
New +$19.4K ﹤0.01% 1094

Other funds holding ONCY

Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SFP
Sandbox Financial Partners Bethesda, Maryland $356M AUM 19.83% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
DA
Doliver Advisors Houston, Texas $442M AUM 34.09% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

CIBC World Market's ONCY Position: Q1 2026 in Review

CIBC World Market reduced its Oncolytics Biotech (ONCY) stake by 14% in Q1 2026, selling an estimated $10K and leaving 60,303 shares worth $51.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1445.

CIBC World Market first reported a position in ONCY in Q4 2019 and has held it in 26 quarters since. The position peaked at $236K in Q1 2021. 59 funds tracked by Wall St. Rank hold ONCY as of Q1 2026.

  • CIBC World Market held 60,303 shares of Oncolytics Biotech worth $51.3K as of Q1 2026.
  • CIBC World Market sold 10,105 Oncolytics Biotech shares in Q1 2026, an estimated $10K.
  • Oncolytics Biotech made up ﹤0.01% of CIBC World Market's portfolio in Q1 2026, its #1445 holding.
  • CIBC World Market first reported a position in Oncolytics Biotech in Q4 2019 and has held it in 26 quarters since.
  • CIBC World Market's Oncolytics Biotech position peaked at $236K in Q1 2021.
  • 59 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q1 2026.

Based on CIBC World Market's 13F filing for Q1 2026, filed 14 May 2026.